2023NICE技术鉴定指导意见：纳武单抗联合氟嘧啶类和铂类化疗治疗未经治疗的不可切除的晚期、复发性或转移性食管鳞状细胞癌TA865

NENatonalinsutute forHealth and Care ExcellenceNICE贝guidanceNivolumab withfluoropyrimidine-andplatinum-basedchemotherapy foruntreated unresectableadvanced,recurrent,ormetastatic oesophagealsquamous cell carcinomaTechnology appraisal guidancePublished:8 February 2023www.nice.org.uk/guidance/ta865NICE 2023.All rights reserved.Subject to Notice of rights(https://www.nice.org.uk/terms-and-conditions#notice-of-rights).